Literature DB >> 3566269

Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity.

S D Feighner, M P Dashkevicz.   

Abstract

A radiochemical method was developed to estimate cholyltaurine hydrolase potentials and rates of cholyltaurine hydrolysis in chicken intestinal homogenates. This method was used to monitor the effects of antibiotic feed additives on cholyltaurine hydrolase activity. Avoparcin, bacitracin methylenedisalisylic acid, efrotomycin, lincomycin, penicillin G procaine, and virginiamycin improved rate of weight gain and feed conversion of chicks and decreased cholyltaurine hydrolase activity in ileal homogenates relative to those of nonmedicated control birds. The results provided the first evidence that feeding selected antibiotics at subtherapeutic levels can affect bile acid-transforming enzymes in small-intestinal homogenates. The inverse relationship between growth performance and cholyltaurine hydrolase activity raises the possibility that specific inhibitors of this enzyme may promote weight gain and feed conversion in livestock and thereby reduce or eliminate the need for antibiotic feed additives.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566269      PMCID: PMC203661          DOI: 10.1128/aem.53.2.331-336.1987

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  33 in total

1.  Effect of barbituric acid and chlortetracycline upon growth, ammonia concentration, and urease activity in the gastrointestinal tract of chicks.

Authors:  L H Harbers; A P Alvares; A I Jacobson; W J Visek
Journal:  J Nutr       Date:  1963-05       Impact factor: 4.798

2.  A mechanism of the vitamin-sparing effect of antibiotics.

Authors:  W J MONSON; A E HARPER; M E WINJE; C A ELVEHJEM; R A RHODES; W B SARLES
Journal:  J Nutr       Date:  1954-04-10       Impact factor: 4.798

3.  Effect of antibiotics on intestinal microflora and on growth of turkeys and pigs.

Authors:  J M SIEBURTH; J GUTIERREZ; J McGINNIS; J R STERN; B H SCHNEIDER
Journal:  Proc Soc Exp Biol Med       Date:  1951-01

4.  Stimulatory effect of aureomycin on the growth of chicks.

Authors:  A R WHITEHILL; J J OLESON; B L HUTCHINGS
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

5.  Intestinal enzyme activities in germfree, conventional, and gnotobiotic rats associated with indigenous microorganisms.

Authors:  Y Kawai; M Morotomi
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

Review 6.  Role of the gut microflora in metabolism of lipids and sterols.

Authors:  H Eyssen
Journal:  Proc Nutr Soc       Date:  1973-09       Impact factor: 6.297

7.  Fat absorption by germ-free chicks.

Authors:  F M Boyd; H M Edwards
Journal:  Poult Sci       Date:  1967-11       Impact factor: 3.352

8.  Influence of certain indigenous gastrointestinal microorganisms on duodenal alkaline phosphatase in mice.

Authors:  D P Yolton; D C Savage
Journal:  Appl Environ Microbiol       Date:  1976-06       Impact factor: 4.792

9.  Effects of Aureomycin on bile acids in rats.

Authors:  D C Madsen; B S Wostmann; M Beaver; L Chang
Journal:  J Lab Clin Med       Date:  1978-04

10.  Bile acid deconjugation and attachment of chicken gut bacteria: their possible role in growth depression.

Authors:  C B Cole; R Fuller
Journal:  Br Poult Sci       Date:  1984-04       Impact factor: 2.095

View more
  57 in total

1.  Quantitative determination of bile salt hydrolase activity in bacteria isolated from the small intestine of chickens.

Authors:  Ane Knarreborg; Ricarda M Engberg; Søren K Jensen; Bent B Jensen
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

2.  Multiple forms of bile salt hydrolase from Lactobacillus sp. strain 100-100.

Authors:  S G Lundeen; D C Savage
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

Review 3.  A special fondness for lactobacilli.

Authors:  Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

Review 4.  Who are we? Indigenous microbes and the ecology of human diseases.

Authors:  Martin J Blaser
Journal:  EMBO Rep       Date:  2006-10       Impact factor: 8.807

Review 5.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

6.  Development of a differential medium for bile salt hydrolase-active Lactobacillus spp.

Authors:  M P Dashkevicz; S D Feighner
Journal:  Appl Environ Microbiol       Date:  1989-01       Impact factor: 4.792

7.  Impact of feed supplementation with antimicrobial agents on growth performance of broiler chickens, Clostridium perfringens and enterococcus counts, and antibiotic resistance phenotypes and distribution of antimicrobial resistance determinants in Escherichia coli isolates.

Authors:  Moussa S Diarra; Fred G Silversides; Fatoumata Diarrassouba; Jane Pritchard; Luke Masson; Roland Brousseau; Claudie Bonnet; Pascal Delaquis; Susan Bach; Brent J Skura; Edward Topp
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

8.  Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters.

Authors:  Zhong Wang; Ximin Zeng; Yiming Mo; Katie Smith; Yuming Guo; Jun Lin
Journal:  Appl Environ Microbiol       Date:  2012-10-12       Impact factor: 4.792

9.  Purification and Characterization of Conjugated Bile Salt Hydrolase from Bifidobacterium longum BB536.

Authors:  J Grill; F Schneider; J Crociani; J Ballongue
Journal:  Appl Environ Microbiol       Date:  1995-07       Impact factor: 4.792

10.  Vancomycin treatment of infective endocarditis is linked with recently acquired obesity.

Authors:  Franck Thuny; Hervé Richet; Jean-Paul Casalta; Emmanouil Angelakis; Gilbert Habib; Didier Raoult
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.